Anne Wojcicki, co-founder and former CEO of 23andMe, led a nonprofit, the TTAM Research Institute, which has secured a $305 million deal to acquire the majority of 23andMe’s assets after outbidding Regeneron’s $256 million offer. The agreement ensures continued commitment to consumer genetic data privacy, opt-out capabilities for consumers, and formation of a privacy advisory board. The bankruptcy court hearing is scheduled for June 17. This acquisition underscores the evolving ownership landscape in consumer genetic testing.